5

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: February 6, 2014
Period of Report: December 31, 2013
Accession Number: 0001237899-14-000013

View Document ↗ View on SEC.gov ↗